MYCN and prostate cancer: The overexpression of MYCN is not limited to gliomas, including astrocytoma, meningioma, and glioblastoma, but is also detected in various other cancer types, including prostate cancer, hematological malignancies, lung cancer, and pancreatic cancer.21